« Comments on "improved" NDA Approvals in 2011 | Main | Pharma R&D Spending May Be Down But Amgen's Is Up 26%! »

07/29/2011

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b01539044a8d5970b

Listed below are links to weblogs that reference Court Rules on AMP vs USPTO (i.e. Myriad) Case :

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

July 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31    

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada